Literature DB >> 2787483

Chronic experimental allergic neuritis in Lewis rats.

A M Adam1, P F Atkinson, S M Hall, R A Hughes, W A Taylor.   

Abstract

An experimental chronic relapsing demyelinating neuropathy was produced by immunizing adult Lewis rats with bovine myelin in low (2.5 mg) and high (5 mg) doses, with and without Mycobacterium tuberculosis in the adjuvant. Each regime produced a similar disease course: acute severe hind limb weakness was followed by apparent recovery and then reappearance of mild neurological deficit with occasional spontaneous exacerbations. The partially recovered animals were relatively resistant to reimmunization with myelin. Immunization of four-week-old rats with myelin in complete adjuvant produced disease with a similar course. Subsequent immunization of these juvenile rats with adjuvant alone precipitated exacerbations. In the late stages, the prominent changes in peripheral nerves and nerve roots were axon loss, axonal regeneration and remyelination while inflammatory cell infiltration was confined to occasional foci. Onion bulb formation was extremely common in the dorsal root ganglia and affected in particular the nerve fibres close to the dorsal root ganglion cells. The cells forming the onion bulbs resembled the satellite cells surrounding the axon hillocks. Onion bulb formation also occurred in the portion of the ventral roots adjacent to the dorsal root ganglion but was rare elsewhere. Immunocytochemistry revealed only occasional lymphocyte infiltration but there was increased Class I and Class II MHC antigen expression throughout the peripheral nervous system. The results are relevant to the interpretation of biopsies from patients with chronic demyelinating neuropathy of possible inflammatory or autoimmune origin.

Entities:  

Mesh:

Year:  1989        PMID: 2787483     DOI: 10.1111/j.1365-2990.1989.tb01226.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  4 in total

1.  Axonal and perikaryal involvement in chronic inflammatory demyelinating polyneuropathy.

Authors:  M Nagamatsu; S Terao; K Misu; M Li; N Hattori; M Ichimura; M Sakai; H Yamamoto; H Watanabe; S Riku; E Ikeda; J Hata; M Oda; M Satake; N Nakamura; S Matsuya; Y Hashizume; G Sobue
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-06       Impact factor: 10.154

2.  Efficiency of long-term treatment with intravenous immunoglobulins correlates with reduced autoreactive T cell responses in chronic inflammatory demyelinating polyneuropathy patients.

Authors:  J Klehmet; C Meisel; A Meisel
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

3.  Suppression of chronic experimental autoimmune neuritis by nasally administered recombinant rat interleukin-6.

Authors:  G Deretzi; S Pelidou; L Zou; C Quiding; E Mix; M Levi; B Wahren; J Zhu
Journal:  Immunology       Date:  1999-05       Impact factor: 7.397

4.  Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins.

Authors:  Mohamed Mahdi-Rogers; Yusuf A Rajabally
Journal:  Biologics       Date:  2010-03-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.